Slide 1: May 2023 Investor Presentation: Transforming Biospecimen Procurement
May 2023 Investor Presentation Transforming Biospecimen Procurement An online marketplace for human biospecimens
Slide 2: Forward-looking statements disclaimer
This presentation may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “w
Slide 3: Investor Highlights
3 1. Early-stage opportunity with a first mover advantage 2. Unique two-sided marketplace disrupting the biospecimen procurement process 3. Strong revenue growth with a 7-year CAGR of 48% 4. Growing data asset that’s a key enabler and differentiator Investor Highlights >200 Healthcare Provider / Sup
Slide 4: Our Vision
Our Vision Accelerate scientific discovery via an online marketplace that empowers researchers to instantly search for and gain access to patients, biospecimens, and data across a global network of healthcare providers. 4
Slide 5: Human Biospecimens are Essential for Life Science R&D
Human Biospecimens are Essential for Life Science R&D Basic Research Biomarker Identification & Validation Drug Discovery & Development Diagnostics Discovery & Validation Biofluid s Solid Tissue Stem & Immune Cells Plasma, Serum, Urine, Saliva Industr y Academi a Governme nt 5 Lung, Breast, Colon, B
Slide 6: Large and Inefficient Biospecimen Market
10 - 15% Annual Growth Fueled by precision and regenerative medicine research 2 Disconnected Market Participants in Need of a Marketplace Solution With an Inefficient Supply Chain Manual processes plus fragmentation make it ripe for an online marketplace solution Large and Inefficient Biospecimen Ma
Slide 7: Market Inefficiencies
Market Inefficiencies PROVIDER RESEARCHER Scientist / Informaticist Procurem ent Legal & Compliance IT / Informaticist Scientist & Informaticist Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations PATIENTS PROVIDERS RESEARCHE
Slide 8: Inefficiencies Lead to Losses
Inefficiencies Lead to Losses Providers miss revenue and research opportunities > 3 Billion clinical specimens are discarded annually worldwide 5 > 1 Billion Patient encounters yearly in the U.S. where a specimen could be provided for research 4 > 800 Million banked specimens are in biorepository in
Slide 9: Full-Service Procurement
Full-Service Procurement We Not Only Connect Suppliers and Customers, but Also Manage the Entire Procurement Process SPECIMEN SEARCH & SELECTION SPECIMEN LOGISTICS SPECIMEN MANAGEMENT DATA MANAGEMENT STUDY/ORDER MANAGEMENT SUPPLIER SITE TRAINING COLLECTION KIT BUILDING COMPLIANCE MANAGEMENT STUDY DE
Slide 10: The iSpecimen Marketplace Solution
The iSpecimen Marketplace® Solution 10 PROVIDER Procurement Principal Investigator / Operations IT / Informaticist PATIENTS Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations Scientist & Informaticist Blood / Pheresis Center
Slide 11: Suppliers and Researchers Benefit
Advance Discovery Support research mission and advance diagnostic, therapeutic, and vaccine research Increase Revenue Instantly connect to a global network of researchers Ensure Compliance On a platform that protects the privacy and security of patient information Accelerate Research Search for spec
Slide 12: Growing Supplier Adoption
Growing Supplier Adoption 1000+ Hospitals Also includes two Healthcare Information Exchanges ▲ 47% CAGR Number of Suppliers (2015 – Q123) WORLDWIDE COVERAGE United States United Kingdom Germany France Ukraine Georgia Bulgaria Russian Federation India Peru Dominican Republic Jamaica Spain Mexico Neth
Slide 13: Growing Researcher Adoption
Cumulative Customer Organizations with Purchases 2015 – Q1 2023 ▲ 53% CAGR Customers (2015 – Q123) Annual Revenue ($000) 2015 – Q1 2023 (Unaudited) ▲ 48% CAGR Revenue (2015 – 2022) Growing Researcher Adoption 70% of the Top 20 Pharma Companies and 70% of the Top 20 IVD Companies Worldwide are iSpeci
Slide 14: Growing Marketplace Adoption
Cumulative Researcher and Supplier Marketplace Users 2015 – Q1 2023 ▲ 85% CAGR Registered Users (2015 – Q123) Growing Marketplace Adoption ~2,700 Unique searches performed by researchers in the iSpecimen Marketplace in 2022 14 Annual Researcher and Supplier Marketplace Logins* 2015 – Q1 2023 ▲ 42% C
Slide 15: Growing Data Asset
“Utilization of sample data for research and for monetization is the next key value driver for the biobanks.” - Frost & Sullivan, Global Biobanking Market Landscape Growing Data Asset Banked Specimen Records Patient Records Medical Condition Records Clinical Specimen Records Laboratory Test Records
Slide 16: Statements of Operations
QisPECIMEN Statements of Operations ispecimen Inc. Condensed Statement of Operations (Unaudited) Three Months Ended March 31, 2023 2022 Revenue 2,950,197 2,518,660 Operating expenses: Cost of revenue 4,146,912 4,165,917 ane 834 407 5971522 Revenue - Q122 vs. Q123 Sales and marketing 962,169 747,432
Slide 17: Balance Sheets
Balance Sheets {specimen ine. ASSETS (Cath and cath equnelents Avalbiersale oo LWABILITIES AND STOCKHOLDERS" EQUITY ure QisPeciEN
Slide 18: Fully Diluted Shares of Common Stock Outstanding
Fully Diluted Shares of Common Stock Outstanding 18
Slide 19: Tracy Curley, Chief Executive Officer, Chief Financial Officer and Treasurer
Tracy Curley | Chief Executive Officer, Chief Financial Officer and Treasurer Ms. Curley brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen and joined iSpecimen in August 2020. She came to iSpecimen a
Slide 20: Investor Summary
20 1. $3B-$4B global biospecimen market growing at 10-15% per year 2. Early-stage opportunity with a first mover advantage 3. Unique two-sided marketplace disrupting the biospecimen procurement process 4. Strong revenue growth with a 7-year CAGR of 48% 5. Growing data asset that’s a key enabler and
Slide 21: Sign up for a free iSpecimen Marketplace account
Sign up for a free iSpecimen Marketplace account at iSpecimen.com Contact us. iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com Be a part of the biospecimen revolution
Slide 22: Appendix
Appendix 22
Slide 23: Strategic Evolution
PHASE 3 Expansion via the Online iSpecimen Marketplace™ START UP Company Ideation and Self-Funding PHASE 1 Proof of Concept PHASE 2 Critical Mass of Suppliers and Early Customer Adoption 2010 – 2011 2012 – 2013 2014 – 2017 2018 – 2022 0 Customers 1 Supplier Agreement 0 Specimen Records 0 Patien
Slide 24: iSpecimen Marketplace UI/UX
iSpecimen Marketplace UI/UX Click Search to start searching for specimens 24
Slide 25: iSpecimen Marketplace UI/UX
2 5 iSpecimen Marketplace UI/UX Use search bar to quickly find specimens that match search criteria
Slide 26: Refine Search Results Using Sliders and Check Boxes
Refine Search Results Using Sliders and Check Boxes iSpecimen Marketplace UI/UX 26
Slide 27: View Quote Request and Add More Specimens
View Quote Request and Add More Specimens Request a Quote iSpecimen Marketplace UI/UX 27 Track and Manage Requests
Slide 28: Sources Cited
28 Page Note Source Cited 7 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End-use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, January 2021;
Slide 29: iSpecimen Marketplace
@ iSPECIMEN Marketplace’